 |
BioWorld-International-2006-02-01
After Recommendation, First Biosimilar Approval Imminent
After Recommendation, First Biosimilar Approval Imminent
LONDON - Europe has opened the floodgates to generic biopharmaceuticals, agreeing that the human growth hormone Omnitrope, manufactured by Sandoz GmbH, is equivalent in quality, safety and efficacy to the registered originator product. (BioWorld International)